# Diaphragmatic downward excursion as a novel metric for assessing Valsalva maneuver efficacy in patent foramen ovale detection by contrast transthoracic echocardiography

**Authors:** Yun Li, Anni Chen, Jianbo Zhu, Lei Zhu, Turgunov Boburjon, Zhenzhen Jiang, Xiatian Liu

PMC · DOI: 10.3389/fcvm.2025.1616241 · Frontiers in Cardiovascular Medicine · 2025-12-19

## TL;DR

This study introduces diaphragmatic downward excursion as a new way to measure the effectiveness of a breathing maneuver used to detect heart defects with ultrasound.

## Contribution

The study introduces diaphragmatic downward excursion as a novel, objective metric for assessing Valsalva maneuver efficacy in contrast transthoracic echocardiography.

## Key findings

- DDE-RRA was significantly lower in patients with adequate Valsalva maneuvers compared to those without.
- A cutoff value of 5 mm for DDE-RRA showed high sensitivity and specificity for evaluating VM efficacy.
- DDE-RRA outperformed conventional hemodynamic parameters in assessing VM effectiveness.

## Abstract

Contrast transthoracic echocardiography (c-TTE) is widely used for the diagnosis of patent foramen ovale (PFO), where the Valsalva maneuver (VM) serves as the standard provocative maneuver to optimize detection. This study aimed to evaluate diaphragmatic downward excursion (DDE) as a novel c-TTE–based parameter for objectively quantifying VM efficacy, thereby establishing a standardized assessment metric.

We studied 145 patients with high clinical suspicion of PFO-related conditions. All participants underwent both c-TTE and contrast transesophageal echocardiography (c-TEE) examinations. Based on intraoral expiratory pressure exceeding 40 mmHg under c-TTE, patients were divided into adequate Valsalva maneuver (AVM) group (n = 90) and non-adequate Valsalva maneuver (non-AVM) group (n = 55). We compared the two groups in terms of DDE at the roof of the right atrium (DDE-RRA) and intracardiac hemodynamic parameters.

DDE-RRA was significantly lower in the AVM group than in the non-AVM group (7.3 mm vs. 3.1 mm, P < 0.001). ROC analysis identified 5 mm as the optimal cutoff value for evaluating VM efficacy, with a sensitivity of 77.8%, specificity of 92.7%, and an AUC of 0.90. The kappa test showed good agreement between DDE-RRA and insufflation manometry (kappa = 0.63, P < 0.001). Furthermore, the DeLong test demonstrated that the AUC of DDE-RRA was significantly greater than that of all assessed intracardiac hemodynamic parameters, including mitral and tricuspid peak E and A-wave velocities, as well as mitral and tricuspid velocity time integrals (all P < 0.05).

DDE provides a simple and objective method for assessing VM efficacy under c-TTE, showing superior diagnostic performance compared with conventional intracardiac parameters. As this represents an initial attempt, further studies incorporating invasive validation are needed to confirm its clinical value.

## Linked entities

- **Diseases:** patent foramen ovale (MONDO:0020439)

## Full-text entities

- **Diseases:** PFO (MESH:D054092)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12771766/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12771766/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12771766/full.md

---
Source: https://tomesphere.com/paper/PMC12771766